Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 9, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Mohs micrographic surgery for mucocutaneous malignancies.

Lester J Fahrner1

  • 1Department of Dermatology, Christie Clinic, 101 West University Avenue, Champaign, IL 61820, USA. lfahrner@christieclinic.com

Oral and Maxillofacial Surgery Clinics of North America
|December 20, 2007
PubMed
Summary

Mohs micrographic surgery offers the lowest recurrence rates for mucocutaneous malignancies by integrating surgical removal with microscopic analysis. This technique effectively removes cancerous tissue while preserving healthy skin, making it a preferred treatment for carcinomas.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Total artificial heart implantation: clinical indications, expected postoperative imaging findings, and recognition of complications.

AJR. American journal of roentgenology·2014
Same author

Structural and functional optical imaging of three-dimensional engineered tissue development.

Tissue engineering·2005
See all related articles

Area of Science:

  • Dermatology
  • Surgical Oncology
  • Pathology

Background:

  • Mucocutaneous malignancies require precise surgical removal to minimize recurrence and preserve tissue.
  • Traditional surgical methods may have higher recurrence rates or lead to excessive tissue loss.

Purpose of the Study:

  • To describe Mohs micrographic surgery as a specialized technique for treating mucocutaneous malignancies.
  • To highlight the advantages of Mohs surgery in achieving tumor-free margins and conserving healthy tissue.

Main Methods:

  • Mohs micrographic surgery involves the surgeon performing the excision, orienting the tissue, preparing slides, and interpreting microscopic findings.
  • This integrated approach allows for immediate assessment of tumor margins during the surgical procedure.

More Related Videos

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Related Experiment Videos

Last Updated: Jul 9, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Main Results:

  • Mohs surgery demonstrates the lowest recurrence rates among surgical techniques for these malignancies.
  • The technique maximizes the conservation of tumor-free skin compared to other methods.

Conclusions:

  • Mohs micrographic surgery is a highly effective and tissue-sparing treatment for selected mucocutaneous carcinomas.
  • Its integrated approach ensures complete tumor removal and is considered the preferred method in specific cases due to its low recurrence rate.